COCP earnings: a negative outcome, -10.5%

On August 14, 2024, Cocrystal Pharma, Inc. reached its earnings. The result was a negative outcome, and the stock moved -10.5% in the window around the event. It had already run -19.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.